XTL BIOPHARMACEUTICALS LTD Quarterly Assets in USD from Q4 2016 to Q4 2024

Taxonomy & unit
ifrs-full: USD
Summary
Xtl Biopharmaceuticals Ltd quarterly Assets history and growth rate from Q4 2016 to Q4 2024.
  • Xtl Biopharmaceuticals Ltd Assets for the quarter ending December 31, 2024 was $8.55M, a 252% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $8.55M +$6.12M +252% Dec 31, 2024 20-F 2025-04-30
Q2 2024 $5.84M Aug 14, 2024 20-F 2025-04-30
Q4 2023 $2.43M -$1.76M -42% Dec 31, 2023 20-F 2025-04-30
Q4 2022 $4.19M -$2.43M -36.7% Dec 31, 2022 20-F 2023-03-22
Q2 2022 $5.76M -$1.2M -17.2% Jun 30, 2022 6-K 2022-08-24
Q4 2021 $6.62M +$115K +1.77% Dec 31, 2021 20-F 2023-03-22
Q2 2021 $6.95M Jun 30, 2021 6-K 2021-08-24
Q4 2020 $6.5M -$709K -9.83% Dec 31, 2020 20-F 2022-03-30
Q4 2019 $7.21M -$1.36M -15.9% Dec 31, 2019 20-F/A 2021-05-19
Q4 2018 $8.58M +$1.99M +30.2% Dec 31, 2018 20-F 2020-03-12
Q4 2017 $6.59M +$3.57M +118% Dec 31, 2017 20-F 2019-03-11
Q4 2016 $3.02M Dec 31, 2016 20-F 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.